Synergetic effects of isopropyl alcohol (IPA) and isopropyl myristate (IPM) on the permeation of betamethasone-17-valerate from semisolid Pharmacopoeia bases

Journal of Drug Delivery Science and Technology

Volumn 17, Issue 5, 2007, Pages 1-8

  Mitriaikina, S ^a   Muller Goymann C C ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Betamethasone 17 valerate; Dermal drug delivery; Penetration enhancers; Semisolid formulations; Stratum corneum; Synergetic effects

Indexed keywords

2 PROPANOL; BETAMETHASONE; BETAMETHASONE VALERATE; FATTY ALCOHOL; MYRISTIC ACID ISOPROPYL ESTER;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; MEDICAL LITERATURE; STEADY STATE; STRATUM CORNEUM;

EID: 36048997298     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-2247(07)50052-3     Document Type: Article

References (73)

1. Hoare C., Li W., Williams H. - Systematic review of treatments for atopic eczema. - Health Technol. Assess, 4 (37), 1-191, 2000.
2. Mason J., Mason A.R., Cork M. J. - Topical preparations for the treatment of psoriasis: a systematic review. - Br. J. Dermatol., 146 (3), 351-354, 2002.
3. Schäfer-Korting M., Korting H.C. -Topische Glucocorticoidtherapie bei Bronchialasthma und entzündlichen Dermatosen. - Pharmazie in unserer Zeit, 32, 306-312, 2003.
4. Rogalski Ch., Haustein U.F., Glander H.J., Paasch, U.- Extensive striae distensae as a result of topical corticosteroid therapy in psoriasis vulgaris. - Acta Derm. Venerol., 83, 54-55, 2003.
5. Schäfer-Korting M., Kleuser B., Ahmed M., Höltje H.-D., Korting H.C. - Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action.- Skin. Pharmacol. Physiol., 18, 103-114, 2005.
6. Green C., Colquitt J.L., Kirby J., Davidson P. - Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. - Br. J. Dermatol., 152 (1), 130-141, 2005.
7. Yip Y.W., Li Wan Po A. - The stability of betamethasone-17-valerate in semi-solid bases. - J. Pharm. Pharmacol., 31, 400-402, 1979.
8. Bundgaard H., Hansen J. - Studies on the stability of corticosteroids. VI. Kinetics of the rearrangement of betamethasone-17-valerate to the 21-valerate ester in aqueous solution. - Int. J. Pharm., 7, 197-203, 1981.
9. Cheung Y.W., Li Wan Po A., Irwin W.J. - Cutaneous biotransformation as a parameter in the modulation of the activity of topical corticosteroids. - Int. J. Pharm., 26, 175-189, 1985.
10. Schackert C., Korting H.C., Schäfer-Korting M. - Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. - Biodrugs, 13 (4), 267-277, 2000.
11. Coert A., Verheijen F., Horspool L.J.I., Mol J.A. - Aspects of pharmacodynamics and biotransformation of the glucocorticoid resocortol butyrate. - J. Vet. Pharmacol. Therap., 27, 309-315, 2004.
12. Elias P.M. - Epidermal lipids, barrier function, and desquamation. - J. Invest. Dermatol., 80, 44-49, 1983.
13. Forslind B. - A domain mosaic model of the skin barrier. - Acta Derm., Venereol., 74, 1-6, 1994.
14. Moore D.J., Rerck M.E. - Insights into the molecular organisation of lipids in the skin barrier from infrared spectroscopy studies of stratum corneum lipid models. - Acta Derm. Venereol. Suppl., 208, 16-22, 2000.
15. Bouwstra J.A., Pilgram G., Gooris G.S., Koerten H., Ponec M. - New aspects of the skin barrier organization. - Skin Pharm. Skin Physiol., 14, 52-62, 2001.
16. Norlen L. - Skin barrier formation: the membrane folding model. - J. Invest. Dermatol, 117, 823-829, 2001.
17. Silva C.L., Nunes S.C.C., Eusebio M.E.S., Pais A.A.C.C., Sousa J.J.S. - Thermal behavior of human stratum corneum. - Skin Pharmacol. Physiol., 19, 132-139, 2006.
18. Moser K., Kriwet K., Naik A., Kalia Y.N., Guy R.H. - Passive skin penetration enhancement and its quantification in vitro. - Eur. J. Pharm. Biopharm., 52, 103-112, 2001.
19. Beastall J.C., Hadgraft J., Washington C. - Mechanism of action of azone as a percutaneous penetration enhancer: lipid bilayer fluidity and transition temperature effects. - Int. J. Pharm., 43, 207-213, 1988.
20. Bouwstra J.A., Peschier L.J.C., Brussee J., Bodde H.E. - Effect of N-alkyl-azocycloheptan-2-ones including azone on the thermal behaviour of human stratum corneum. - Int. J. Pharm., 52, 47-54, 1989.
21. Loth H. - Skin permeability. - Meth. Find. Exp. Clin. Pharmacol. 11 (3), 155-164, 1989.
22. Francoeur M.L., Golden G.M., Potts R.O. - Oleic acid: its effects on stratum corneum in relation to (trans) dermal drug delivery. - Pharm. Res., 7, 621-627, 1990.
23. Yamane M.A., Williams A.C., Barry B.W. - Effects of terpens and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. - Int. J. Pharm., 116, 231-251, 1995.
24. Harrison J.E., Groundwater P.W., Brain K.R., Hadgraft J. - Azone induced fluidity in human stratum corneum. A Fourier transform infrared spectroscopy investigation using the perdeuterated analogue. - J. Controlled Release, 41, 283-290, 1996.
25. Harrison J.E., Watkinson A.C., Green D.M., Hadgraft J., Brain K. - The relative effect of azone and transcutol on permeant diffusivity and solubility in human stratum corneum. - Pharm. Res., 13, 542-546, 1996.
26. El-Kattan A.F., Asbill C.S., Kim N., Michniak B.B. - Effect of formulation variables on the percutaneous permeation of keto-profen from gel formulations. - Drug Deliv., 7, 147-153, 2000.
27. Jiang S.J., Zhou X.J. - Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. - Biol. Pharm. Bull., 26, 66-68, 2003.
28. Nanayakkara G.R., Bartlett A., Forbes B., Marriott C., Whitfield P.J., Brown M.B. - The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. - Int. J. Pharm., 301, 129-139, 2005.
29. Yazdanian M., Chen E. - The effect of diethylene glycol monoethyl ether as a vehicle for topical delivery of ivermectin. - Vet. Res. Commun., 19, 309-319, 1995.
30. Horne D.C. - A medical library for the public: starting and running a consumer health library. - North. Carolina Libraries., 57 (3), 110-113, 1999.
31. Kobayashi Y., Nakamura H., Sugibayashi K., Morimoto Y. - Estimation of action site of L-lactic acid-ethanol-isopropylmyristate mixed system for its enhancing effect on the skin permeation of ketotifen. - Int. J. Pharm., 156, 153-162, 1997.
32. Arellano A., Santoyo S., Martin C., Ygartua P. - Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels. - Eur. J. Pharm. Sci., 7(2), 129-135, 1999.
33. Cha B.J., Lee E.D., Kim W.B., Chung S.J., Lee M.H., Shim C.K. - Enhanced skin permeation of a new capsaicin derivative (DA-5018) from a binary vehicle system composed of isopropyl myristate and ethoxydiglycol. - Arch. Pharm. Res., 24 (3), 224-228, 2001.
34. Brinkmann I., Müller-Goymann C.C. - Role of isopropyl myristate, isopropyl alcohol and a combination of both in hydrocortisome permeation across the human stratum corneum. - Skin Pharmacol. Appl. Skin Physiol., 16, 393-404, 2003.
35. Gungor S., Bergisadi N. - Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin. - Pharmazie, 59, 39-41, 2004.
36. Jiang J., Wang R.K. - Comparing the synergistic effects of oleic acid and dimethyl sulfoxide as vehicles for optical clearing of skin tissue in vitro. - Phys. Med. Biol., 49, 5283-5294, 2004.
37. Panchagnula R., Desu H., Jain A., Khandavilli S. - Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation. - Farmaco, 60, 894-899, 2005.
38. Narasimha M.S., Zhao Y.L., Hui S.W., Sen A. - Synergistic effect of anionic lipid enhancer and electroosmosis for transcutaneous delivery of insulin. - Int. J. Pharm., 326 (1), 1-6, 2006.
39. Wotton K., Mollgaard B., Hadgraft J., Hoelgaard A. - Vehicle effect on topical drug delivery: effect of Azone on the cutaneous penetration of metronidazole and propylene glycol. - Int. J. Pharmacol., 24, 19-26, 1985.
40. Kurihara-Bergstrom T., Knutson K., Denoble L.J., Goates C.Y. - Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. - Pharm. Res., 7, 762-766, 1990.
41. Rojas J., Falson F., Couarragze G., Francis A., Puisieux F. - Optimization of binary and ternary solvent systems in the percutaneous absorption of morphine base. - Skin Pharmacol. Appl. Skin Physiol., 1, 70-75, 1991.
42. Shu H., Jun H. W. - Effectiveness and mode of action of isopropyl myristate as a permeation enhancer for naproxen through shed snake skin. - J. Pharm. Pharmacol., 48 (8), 812-816, 1996.
43. Bach M., Lippold B.C. - Influence of penetration enhancers on the blanching intensity of betamethasone 17-benzoate. - Int. J. Pharm., 168, 97-108, 1998.
44. Goffin V., Henry F., Pierard-Franchimont C., Pierard G.E. - Penetration enhancers assessed by corneoxenometry. - Skin Pharmacol. Appl. Skin Physiol., 13, 280-284, 2000.
45. Blume B. - Untersuchung der perkutanen Resorption von Betamethason-17, 21-dipropionat aus verschiedenen galenischen Formulierungen am in vitro-Modell des isoliert perfundierten Rindereuters. - Ph. D. Thesis, Univ., Leipzig, Germany, 1996
46. Alberg U., Müller-Goymann C.C. - Modified water containing hydrophlic ointment with suspended hydrocortisone-21-acetate the influence of the microstructure of the cream on the in vitro drug release and in vitro percutaneous penetration. - Eur. J. Pharm. Biopharm., 47 (2), 139-143, 1999
47. Liu P., Bergstrom T.K., Clarke F.H., Gonnella N., Good W.R. - Quantitative evaluation of aqueous isopropanol enhancement of skin flux of terbutaline (sulfate). I. Ion associations and species equilibria in the formulation. - Pharm. Res., 8, 1035-1042, 1992.
48. Liu P., Bergstrom T.K. - Quantitative evaluation of aqueous isopropanol enhancement of skin flux of terbutaline (sulfate). 2. Permeability contributions of equilibrated drug species across human skin in vitro. - J. Pharm. Sciences, 85, 320-325, 1996.
49. Ghanem A.H., Mahmound H., Higuchi W.I., Rohr U.D., Borsadia S., Liu P., Fox J.L., Good W.R. - J. Control. Release, 6, 75-83, 1987.
50. Liu P., Kurihara-Bergstrom T., Good W.R. - Cotransport of estradiol and ethanol through human skin in vitro: understanding the permeant/enhancer flux relationship. - Pharm. Res., 8, 938-944, 1991.
51. Kim Y-H., Ghanem A.H., Mahmound H., Higuchi W.I. - Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: mechanism(s) of action. - Int. J. Pharm., 80, 17-31, 1992.
52. Berner B., Liu P. - In: Percutaneous Penetration Enhancers, E. Smith, H. I. Maibach Eds., CRC Press, Inc., 1995, pp. 44-60.
53. Fang L., Numajiri S., Kobayashi D., Morimoto Y. - The use of complexation with alkanolamines to facilitate skin permeation of methamic acid. - Int. J. Pharm., 262, 13-22, 2003.
54. Williams A.C., Barry B.W. - Penetration enhancers. - Adv. Drug Deliv. Rev., 56, 603-618, 2004.
55. Franz T.J. - Percutaneous absorption. On the relevance of in vitro data. - J. Invest. Dermatol., 64, 190-195, 1975.
56. Kligmann C.E. - Preparation of isolated sheets of human stratum corneum. - Arch. Dermatol., 88, 702-705, 1964.
57. Van Duzee B.F. - Thermal analysis of human stratum corneum. - J. Invest. Dermatol., 65, 404-408, 1975.
58. Golden G.M., Guzek D.B., Mkie J.E., Potts R.O. - Lipid thermotropic transitions in human stratum corneum. - J. Invest. Dermatol., 86 (3), 255-259, 1986.
59. Bouwstra J.A., De Vries M.A., Gooris G.S., Bras W., Brussee J., Ponec M. - Thermodynamic and structural aspects of the skin barrier. - J. Contrall. Release, 15, 209-220, 1991.
60. Hirvonen J., Rajala R., Vihervaara P., Laine E., Paronen P., Urtti A. - Mechanism and reversibility of penetration enhancers action in the skin. A DSC study. - Eur. J. Pharm. Biopharm., 40 (2), 81-85, 1994.
61. Leopold C.S., Lippold B.C. - An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry (DSC). - J. Pharm. Pharmacol., 47, 276-281, 1995.
62. Leopold C.S., Lippold B.C. - Enhancing effects of lipophilic vehicles on skin penetration on methyl nicotinate in vivo. - J. Pharm. Sci., 84 (2), 195-198, 1995.
63. Smith E.W., Maibach H.I. - In: Percutaneous Penetration Enhancers, E. Smith, H. I. Maibach Eds., CRC Press, Inc., 1995.
64. Winkler A., Müller-Goymann C.C. - The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. - Eur. J. Pharm. Biopharm., 60, 427-437, 2005.
65. Refai H., Müller-Goymann C.C. - The influence of dilution of topical semisolid preparations on hydrocortisone permeation through excised human stratum corneum. - Eur. J. Pharm. Biopharm., 54, 143-150, 2002.
66. Trommer H., Neubert R.H.H. - Overcoming the stratum corneum: the modulation of skin penetration. - Skin Pharmacol. Physiol., 19, 106-121, 2006.
67. Barry B.W. - Mode of action of penetration enhancers in human skin. - J. Control. Release, 6, 85-97, 1987.
68. Brinkmann I., Müller-Goymann C.C. - An attempt to clarify the influence of glycerol, propylene glycol, isopropyl myristate and a combination of propylene glycol and isopropyl myristate on human stratum corneum. - Pharmazie, 60, 215-220, 2005.
69. Golden G.M., Mckie J.E., Potts R.O. - Role of stratum corneum lipid fluidity in transdermal drug flux. - J. Pharm. Sci., 76, 25-28, 1987.
70. Walker M., Hadgraft J. - Oleic acid: a membrane 'fluidiser' or fluid within the membrane? - Int. J. Pharm., 71, R1-R4, 1991.
71. 2H NMR. - Int. J. Pharm., 307, 225-231, 2006.
72. Kriwet K. - Diclofenac-Diethylamin und seine Assoziate mit Phospholipiden: Charakterisierung der Systeme und Einfluss auf Struktur und Permeabilität humanen Stratum corneums. - Ph. D. Thesis, Univ., Braunschweig, Germany, 1994.
73. Glombitza B. - Lipidsysteme als Stratum corneum Modelle Charakterisierung und Eignung für Permeationsuntersuchungen. - Ph. D. Thesis, Univ., Braunschweig, Germany, 2001.